SAMDaily.us | SNOTE | Q | Study Comparing Patients With Lipodystrophy To Patients With Insulin Receptor Mutations

SAMDAILY.US - ISSUE OF JUNE 25, 2020 SAM #6783
SPECIAL NOTICE

Q -- Study Comparing Patients With Lipodystrophy To Patients With Insulin Receptor Mutations

Notice Date: 6/23/2020 12:13:56 PM
Notice Type: Special Notice
NAICS: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contracting Office: NATIONAL INSTITUTES OF HEALTH NICHD BETHESDA MD 20817 USA
ZIP Code: 20817
Solicitation Number: NIH-NICHD-20-145
Response Due: 7/7/2020 6:00:00 AM
Archive Date: 07/08/2020
Point of Contact: April N Martin, Phone: 3014356962
E-Mail Address: april.martin@nih.gov
(april.martin@nih.gov)
Description: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases has a requirement for a study to compare patients with lipodystrophy to patients with insulin receptor mutations. The goal of the study is to compare 30 patients with lipodystrophy not being treated with metreleptin to 30 patients with insulin receptor mutations matched for age, sex�and glycemia using hemoglobin A1c at the time of sample collection. It is hypothesized that, by comparing two different types of insulin resistance, it may reveal novel, direct effects of insulin signaling on the human metabolome.
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/a1ee46241ec547b197b4b75d6fd82862/view)
Place of Performance: Address: Bethesda, MD 20817, USA; Zip Code: 20817; Country: USA
Record: SN05699699-F 20200625/200623230139 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |